The Texas Children's Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder.

OBJECTIVES To develop consensus guidelines for medication treatment algorithms for childhood major depressive disorder (MDD) based on scientific evidence and clinical opinion when science is lacking. The ultimate goal of this approach is to synthesize research and clinical experience for the practitioner and to increase the uniformity of preferred treatment for childhood MDD. A final goal is to develop an approach that can be tested as to whether it improves clinical outcomes for children and adolescents with MDD. METHOD A consensus conference was held. Participants included academic clinicians and researchers, practicing clinicians, administrators, consumers, and families. The focus was to review and use clinical evidence to recommend specific pharmacological approaches for treatment of MDD in children and adolescents. After a series of presentations of current research evidence and panel discussion, the consensus panel met, agreed on assumptions, and drafted the algorithms. The process initially addressed strategies of treatment and then tactics to implement the strategies. RESULTS Consensually agreed-upon algorithms for major depressions (with and without psychosis) and comorbid attention deficit disorders were developed. Treatment strategies emphasized the use of selective serotonin reuptake inhibitors. The algorithm consists of systematic strategies for treatment interventions and recommended tactics for implementation of the strategies, including medication augmentation and medication combinations. Participants recommended prospective evaluation of the algorithms in various public sector settings, and many volunteered as sites for such an evaluation. CONCLUSIONS Using scientific and clinical experience, consensus-derived algorithms for children and adolescents with MDD can be developed.

[1]  D. Spiegel,et al.  Treatment of tricyclic-resistant depression , 1989 .

[2]  J. Mcd..  1996 Academy Research Awards , 1996 .

[3]  C. Hammen,et al.  The context of depression in clinic-referred youth: neglected areas in treatment. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[4]  F. Bloom,et al.  Psychopharmacology: The Fourth Generation of Progress , 1995 .

[5]  J. Swanson,et al.  Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[6]  M. Crismon,et al.  Texas Medication Algorithm Project: definitions, rationale, and methods to develop medication algorithms. , 1998, The Journal of clinical psychiatry.

[7]  N. Ryan,et al.  Lithium antidepressant augmentation in TCA-refractory depression in adolescents. , 1988, Journal of the American Academy of Child and Adolescent Psychiatry.

[8]  S. Kutcher,et al.  Electroconvulsive Therapy in Treatment-Resistant Bipolar Youth , 1995 .

[9]  Alexander L. Miller,et al.  Implementing guidelines and systems of care: Experiences with the Texas Medication Algorithm Project (TMAP) , 1999 .

[10]  H. Sackeim,et al.  Resistance to antidepressant medications and short-term clinical response to ECT. , 1996, The American journal of psychiatry.

[11]  D. Chambless,et al.  Treatments that work. , 1999 .

[12]  F. Benazzi.  Severe Anticholinergic Side Effects with Venlafaxine—Fluoxetine Combination , 1997, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[13]  J. Biederman,et al.  Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome. , 1993, Journal of the American Academy of Child and Adolescent Psychiatry.

[14]  M. Riddle,et al.  Sertraline for Major Depression in Children and Adolescents: Preliminary Clinical Experience , 1995 .

[15]  Glen O. Gabbard,et al.  Treatments of Psychiatric Disorders , 1995, Nature Medicine.

[16]  Philip D. Harvey,et al.  Predictors of medication compliance after hospital discharge in adolescent psychiatric patients. , 1998, Journal of child and adolescent psychopharmacology.

[17]  A. Rush,et al.  Consensus guidelines in the treatment of major depressive disorder. , 1998, The Journal of clinical psychiatry.

[18]  C. Pataki,et al.  The pharmacotherapy of depressive illness in adolescents: an open-label comparison of fluoxetine with imipramine-treated historical controls. , 1999, The Journal of clinical psychiatry.

[19]  J. Guilé.  Sertraline-induced behavioral activation during the treatment of an adolescent with major depression. , 1996, Journal of child and adolescent psychopharmacology.

[20]  S. Preskorn,et al.  Serotonin Syndrome Induced by Venlafaxine and Fluoxetine: A Case Study in Polypharmacy and Potential Pharmacodynamic and Pharmacokinetic Mechanisms , 1998, The Annals of pharmacotherapy.

[21]  M. Strober,et al.  The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine. , 1992, Journal of the American Academy of Child and Adolescent Psychiatry.

[22]  R. Dahl,et al.  Unipolar depression in adolescents: clinical outcome in adulthood. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[23]  A. Nierenberg,et al.  Algorithms for the treatment of subtypes of unipolar major depression. , 1995, Psychopharmacology bulletin.

[24]  A. Rush,et al.  Recurrence of major depressive disorder in hospitalized children and adolescents. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[25]  Myron Genel,et al.  Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents , 1998 .

[26]  C. Pataki,et al.  Complete remission of 'treatment resistant' severe melancholia in adolescents with phenelzine: two case reports. , 1998, Journal of affective disorders.

[27]  M. State,et al.  Effects of Electroconvulsive Therapy in Adolescents with Severe Endogenous Depression Resistant to Pharmacotherapy , 1998, Biological Psychiatry.

[28]  J. Biederman,et al.  Multicenter open-label sertraline study in adolescent outpatients with major depression. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[29]  Ian M. Goodyer,et al.  The Depressed child and adolescent : developmental and clinical perspectives , 2000 .

[30]  A. Rush,et al.  A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. , 1997, Archives of general psychiatry.

[31]  T. Rummans,et al.  Electroconvulsive Therapy in Adolescents. , 1993, Convulsive therapy.

[32]  S Iyengar,et al.  A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. , 1997, Archives of general psychiatry.

[33]  N. Ryan,et al.  MAOIs in adolescent major depression unresponsive to tricyclic antidepressants. , 1988, Journal of the American Academy of Child and Adolescent Psychiatry.

[34]  C. Gillberg,et al.  Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial. , 1997, Archives of general psychiatry.

[35]  T. Crow,et al.  Who Benefits from Electroconvulsive Therapy? , 1992, British Journal of Psychiatry.

[36]  A. Pickles,et al.  Adult outcomes of childhood and adolescent depression. I. Psychiatric status. , 1990, Archives of general psychiatry.

[37]  Rush Aj,et al.  FROM SCIENTIFIC KNOWLEDGE TO THE CLINICAL PRACTICE OF PSYCHOPHARMACOLOGY :CAN THE GAP BE BRIDGED ? , 1995 .

[38]  D. Rosenberg,et al.  Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder. , 1998, Journal of child and adolescent psychopharmacology.

[39]  J. Biederman,et al.  A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder. , 1995, The Journal of nervous and mental disease.

[40]  J. Swanson,et al.  The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[41]  Harrington Rc.  Adult outcomes of childhood and adolescent depression. , 1991 .

[42]  M. Bertagnoli,et al.  A review of ECT for children and adolescents. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.

[43]  J. March,et al.  Obsessive-compulsive disorder in children and adolescents: a review of the past 10 years. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[44]  D H Barlow,et al.  Advances in the psychosocial treatment of anxiety disorders. Implications for national health care. , 1996, Archives of general psychiatry.

[45]  L. Freeman,et al.  Children's Depression Rating Scale - Revised (September 1984) , 1985 .

[46]  M. Strober.  Mixed mania associated with tricyclic antidepressant therapy in prepubertal delusional depression: three cases. , 1998, Journal of child and adolescent psychopharmacology.

[47]  C. Coffey,et al.  Textbook of pediatric neuropsychiatry , 1998 .

[48]  J. Nelson.  Augmentation strategies for treatment of unipolar major depression. , 1997, Modern problems of pharmacopsychiatry.

[49]  R. Balon,et al.  Augmentation with buspirone: a review. , 1995, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[50]  J. Walkup,et al.  Nontricyclic antidepressants: current trends in children and adolescents. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[51]  M. Trivedi,et al.  The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder. , 1999, The Journal of clinical psychiatry.

[52]  R. Dahl,et al.  Childhood and adolescent depression: a review of the past 10 years. Part I. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.